Literature DB >> 22524580

Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.

Ju Young Yoon1, Tai Seung Nam, Myeong Kyu Kim, Jun Eul Hwang, Hyun-Jeong Shim, Sang Hee Cho, Ik Joo Chung, Woo Kyun Bae.   

Abstract

We report a case of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) that developed in a patient with cholangiocarcinoma after receiving oxaliplatin-based chemotherapy. A 62-year-old man had multiple hypodense lesions with delayed enhancement in the both lobes of the liver on abdominal computed tomography. He was treated with 5-fluorouracil, leucovorin and oxaliplatin (100 mg/m(2)). After eight cycles of treatment and a cumulative oxaliplatin dose of 780 mg/m(2), he developed an unsteady gait, dysphagia, weakness of both the upper and lower limbs and impairment of all sensory modalities. Nerve conduction studies confirmed the diagnosis of AIDP. Immunoglobulin G i.v. was administered for 5 days but the neurological deficits of both his upper and lower limbs did not improve. This case highlights unusual peripheral nervous system manifestations in a patient who received chemotherapy with oxaliplatin.
© 2012 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524580     DOI: 10.1111/j.1743-7563.2011.01515.x

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  2 in total

Review 1.  Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature.

Authors:  Evangelia Pappa; Giulia Berzero; Bastien Herlin; Damien Ricard; Camille Tafani; Perrine Devic; Denis Maillet; Alaina Borden; Karine Viala; Thierry Maisonobe; Timothée Lenglet; Nicolas Weiss; Dimitri Psimaras
Journal:  Oncologist       Date:  2019-10-15

Review 2.  Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.

Authors:  Nathan P Staff; Guido Cavaletti; Badrul Islam; Maryam Lustberg; Dimitri Psimaras; Stefano Tamburin
Journal:  J Peripher Nerv Syst       Date:  2019-10       Impact factor: 3.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.